Compile Data Set for Download or QSAR
maximum 50k data
Found 1030 Enz. Inhib. hit(s) with Target = 'Solute carrier family 22 member 12'
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165856(US9067922, 194)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165857(US9067922, 196)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165858(US9067922, 197)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165859(US9067922, 198)
Affinity DataIC50:  792nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165860(US9067922, 199)
Affinity DataIC50:  129nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165861(US9067922, 200)
Affinity DataIC50:  53nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165862(US9067922, 201)
Affinity DataIC50:  74nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165863(US9067922, 202)
Affinity DataIC50:  37nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165864(US9067922, 203)
Affinity DataIC50:  37nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165865(US9067922, 204)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165866(US9067922, 205)
Affinity DataIC50:  2.63E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165867(US9067922, 206)
Affinity DataIC50:  1.08E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165868(US9067922, 207)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165869(US9067922, 208)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165870(US9067922, 209)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165871(US9067922, 210)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165872(US9067922, 211)
Affinity DataIC50: >3.00E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165873(US9067922, 212)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165874(US9067922, 213 | US9067922, 225)
Affinity DataIC50:  2.33E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165875(US9067922, 214)
Affinity DataIC50: >1.15E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165876(US9067922, 215)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165877(US9067922, 216)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165878(US9067922, 217)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165879(US9067922, 218)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165880(US9067922, 219)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165881(US9067922, 220)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165882(US9067922, 221)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165883(US9067922, 222)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165884(US9067922, 223)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165885(US9067922, 224)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165874(US9067922, 213 | US9067922, 225)
Affinity DataIC50:  2.33E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165887(US9067922, 226)
Affinity DataIC50:  1.78E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165888(US9067922, 227)
Affinity DataIC50: >1.00E+4nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165889(US9067922, 228)
Affinity DataIC50:  244nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165890(US9067922, 229)
Affinity DataIC50:  126nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165891(US9067922, 230)
Affinity DataIC50:  62nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165892(US9067922, 231)
Affinity DataIC50:  53nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165893(US9067922, 232)
Affinity DataIC50:  12nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165894(US9067922, 233)
Affinity DataIC50:  233nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165895(US9067922, 234)
Affinity DataIC50:  1.15E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165896(US9067922, 237)
Affinity DataIC50:  8nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165897(US9067922, 238)
Affinity DataIC50:  88nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165898(US9067922, 239)
Affinity DataIC50:  2nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165899(US9067922, 240)
Affinity DataIC50:  106nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165900(US9067922, 241)
Affinity DataIC50:  3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165901(US9067922, 243)
Affinity DataIC50:  1.00E+3nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165902(US9067922, 244)
Affinity DataIC50:  258nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165903(US9067922, 245)
Affinity DataIC50:  472nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165904(US9067922, 246)
Affinity DataIC50:  87nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM165905(US9067922, 247)
Affinity DataIC50:  1nMpH: 7.4Assay Description:Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 1030 total ) | Next | Last >>
Jump to: